Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Pagel

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Blood|December 17, 2016
Neighborhood imbalances: overcoming MCL drug resistanceJohn M Pagel
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Treatment selection in patients with relapsed or refractory follicular lymphomaJohn M Pagel
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Initiation of Treatment in Chronic Lymphocytic LeukemiaJohn M Pagel
Clinical Advances in Hematology & Oncology : H&O|July 29, 2020
Advances in Aggressive Lymphoma From the 2019 American Society of Clinical Oncology Annual Meeting: CommentaryJohn M Pagel
Blood|July 1, 2017
A Richter transformation PD-1 block partyJohn M Pagel
Journal of Hematology & Oncology|April 27, 2021
Current and future treatment strategies in chronic lymphocytic leukemiaKrish Patel, John M Pagel
Current Hematologic Malignancy Reports|June 17, 2019
Exploring a Future for PI3K Inhibitors in Chronic Lymphocytic LeukemiaKrish Patel, John M Pagel
JAMA Oncology|September 8, 2017
Chimeric Antigen Receptor (CAR) T-Cell TherapyJohn M Pagel, Howard Jack West
Therapeutic Advances in Hematology|April 5, 2013
Radiolabeled antibodies directed at CD45 for conditioning prior to allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndromeJohnnie J Orozco, Jill Zeller, John M Pagel
Current Hematologic Malignancy Reports|March 5, 2013
Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemiaRaya Mawad, Jack M Lionberger, John M Pagel
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Blood|December 17, 2016
Neighborhood imbalances: overcoming MCL drug resistanceJohn M Pagel
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Treatment selection in patients with relapsed or refractory follicular lymphomaJohn M Pagel
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Initiation of Treatment in Chronic Lymphocytic LeukemiaJohn M Pagel
Clinical Advances in Hematology & Oncology : H&O|July 29, 2020
Advances in Aggressive Lymphoma From the 2019 American Society of Clinical Oncology Annual Meeting: CommentaryJohn M Pagel
Blood|July 1, 2017
A Richter transformation PD-1 block partyJohn M Pagel
Journal of Hematology & Oncology|April 27, 2021
Current and future treatment strategies in chronic lymphocytic leukemiaKrish Patel, John M Pagel
Current Hematologic Malignancy Reports|June 17, 2019
Exploring a Future for PI3K Inhibitors in Chronic Lymphocytic LeukemiaKrish Patel, John M Pagel
JAMA Oncology|September 8, 2017
Chimeric Antigen Receptor (CAR) T-Cell TherapyJohn M Pagel, Howard Jack West
Therapeutic Advances in Hematology|April 5, 2013
Radiolabeled antibodies directed at CD45 for conditioning prior to allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndromeJohnnie J Orozco, Jill Zeller, John M Pagel
Current Hematologic Malignancy Reports|March 5, 2013
Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemiaRaya Mawad, Jack M Lionberger, John M Pagel
Pageof 19